Product apis-jak-stat

Home > products > apis> jak-stat

Catalog	name	Description	price
R-R-2317	Lorpucitinib CAS No.2230282-02-5	Lorpucitinib/CAS No.2230282-02-5 is a Gut-Restricted JAK Inhibitor for the research of Inflammatory Bowel Disease.	price>
R-R-2318	Ilunocitinib CAS No.1187594-14-4	Ilunocitinib (compound 27)/CAS No.1187594-14-4 is a JAK inhibitor (extracted from patent WO2009114512A1).	price>
R-R-2319	(E/Z)-Zotiraciclib hydrochloride CAS No.1321626-25-8	(E/Z)-Zotiraciclib ((E/Z)-TG02) hydrochloride/CAS No.1321626-25-8 is a potent CDK2, JAK2, and FLT3 inhibitor.	price>
R-R-2320	JAK1-IN-8 CAS No.1973485-18-5	JAK1-IN-8/CAS No.1973485-18-5, a potent JAK1 inhibitor (IC50<500 nM), compound 28, extracted from patent WO2016119700A1.	price>
R-R-2321	GSK2646264 CAS No.1398695-47-0	GSK2646264 (Compound 44)/CAS No.1398695-47-0 is a potent and selective spleen tyrosine kinase (SYK) inhibitor with a pIC50 of 7.1. GSK2646264 also inhibits other kinases with pIC50 values of 5.4, 5.4, 5.3, 5, 4.5, <4.6 and <4.3 against LCK, LRRK2, GSK3β, JAK2, VEGFR2, Aurora B and Aurora A, respectively. GSK2646264 is penetrable into the epidermis and dermis of the skin.	price>
R-C-622	AT9283 cas:896466-04-9	AT9283 inhibits aurora kinase A and B and targets other tyrosine and serine/threonine kinases associated with myeloid cell proliferation.	price>
R-R-2322	JAK3-IN-1 CAS No.1805787-93-2	JAK3-IN-1/CAS No.1805787-93-2 is a potent, selective and orally active JAK3 inhibitor with an IC50 of 4.8 nM. JAK3-IN-1 shows over 180-fold more selective for JAK3 than JAK1 (IC50 of 896 nM) and JAK2 (IC50 of 1050 nM).	price>
R-R-2323	(E/Z)-Zotiraciclib citrate CAS No.1204918-73-9	(E/Z)-Zotiraciclib citrate/CAS No.1204918-73-9 is a potent CDK2, JAK2, and FLT3 inhibitor.	price>
R-R-2324	JAK2 JH2 binder-1 CAS No.2923309-41-3	JAK2 JH2 binder-1 (compound 11)/CAS No.2923309-41-3 is a potent and selective JAK2 JH2 binder, with a Kd of 37.1 nM. JAK2 JH2 binder-1 has the potential for various myeloproliferative neoplasms research.	price>
R-C-625	CP690550 cas:540737-29-9	Tofacitinib citrate(CP-690550 citrate)is a novel inhibitor of JAK with IC50 of 1 nM,20 nM and 112 nM against JAK3,JAK2,and JAK1,respectively.Tofacitinib citrate has anti-infection activity.	price>

...